Knowledge Center
Presentation / Oct 17, 2021
Understanding Dry Powder Inhalers Formulations: Role of Surface Polarity of lactose mixtures
Source:
AAPS 2021
Track: Formulation and Delivery – Chemical
Rapid Fire: Role of Excipients in Formulation & Drug Product Development (CE)
Ìý
![]() Ìý Ìý |
Presenting Author:ÌýRicardo GonçalvesÌý-ÌýAnalytical Scientist, R&D Analytical Development
Ìý
Why do we use small lactose particles to improve Dry Powder Inhaler formulations? Why sieved and milled lactose particles present different properties? This presentation explores the role of surface energetics, measured using inverse gas chromatography, in the behavior of DPI formulations and the implication on their aerodynamic performance.
Ìý
Ìý
Ìý
Also in the Knowledge Center
/ Feb 22, 2017
Webinar - Physical Characterization of Drugs: avoiding surprises during late development
Read more
Scientific Article
/ Sep 08, 2022
Webinar - Dispersome® – Understanding formulation principles and manufacturing behind this new Bioavailability Enhancing Technology
Read more
Scientific Article
Scientific Article